Zhenye Wang

Zhenye Wang is an associate in the Corporate Practice Group in the firm's Shanghai office. 

Areas of Practice

Mr. Wang's practice focuses on corporate transactions (mergers & acquisitions and joint ventures), as well as foreign direct investment for multinational companies in Greater China Region in a wide range of industries. He also has experiences in advising both Chinese domestic and international companies in their cross-border corporate compliance matters.

Articles

China Law Update Blog Posts

• "China Revised Rules for Foreign Investors’ Strategic Investment in A-share Listed Companies," November 11, 2024
• "China Launched Pilot Program Permitting Foreign Enterprises’ Greater Participation in Value-Added Telecommunications Services," November 6, 2024

• "China Expands Pilot Program for Foreign Investment in the Healthcare Sector," September 9, 2024
• "Highlights of the Draft Amendment to the Arbitration Law of China," August 20, 2024

• "Provisional Regulations on Combating Unfair Competition in the Online Sphere: A Step Toward a Healthier Digital Economy," July 19, 2024
• "Amendment to China’s Company Law (1): Contribution of Capital and Authorized Capital Concept," April 19, 2024

• "China Issues Regulations on Facilitating and Regulating Cross-Border Data Flow," April 11, 2024
• “China Raises Turnover Threshold for Anti-Monopoly Filing in M&A Deals,” February 20, 2024
• “Companies in Beijing are Submitting Application Materials Relating to the Security Assessment for Cross- border Data Transfer,” January 22, 2024
• “China Released Draft Rules Regulating and Promoting Cross-Border Data Transfer,” November 16, 2023
• “Overview of Recent Anti-Corruption Enforcement Actions in the Pharmaceutical Industry in China,” September 27, 2023